Influence of complex treatment with use of metformin on the production of the p53 in the patients with type 2 diabetes and metabolic syndrome
The study included 41 patients aged 50.0 (39.0, 55.0) years, of which 29 men (70.7%) and 12 women (29.3%) with diabetes type 2 and metabolic syndrome in terms of voluntary informed consent. We studied the effect of combined treatment (correction of physical activity, the formation of healthy food, m...
Saved in:
Main Authors: | E. N. Chernysheva, T. N. Panova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Healthcare of the Russian Federation. “Kuban State Medical University”
2015-12-01
|
Series: | Кубанский научный медицинский вестник |
Subjects: | |
Online Access: | https://ksma.elpub.ru/jour/article/view/434 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comorbidity of depression and metabolic syndrome: on the question of causal or associative connections
by: N. N. Petrova, et al.
Published: (2024-12-01) -
STRATEGIES FOR THE TREATMENT OF TYPE 1 DIABETES AT THE PRE-CONCEPTION STAGE, DURING PREGNANCY AND CHILDBIRTH
by: Ольга Ивановна Мищенко, et al.
Published: (2020-11-01) -
Liver Damage in Type 1 Diabetes Mellitus
by: A. O. Bueverov, et al.
Published: (2021-06-01) -
ADIPONECTIN, RESISTIN AND HORMONE-METABOLIC PARAMETERS IN MEN WITH HYPOTHYROIDISM AND TYPE 2 DIABETES MELLITUS
by: Андрей Феликсович Вербовой, et al.
Published: (2018-12-01) -
Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers
by: Na Zhang, et al.
Published: (2025-05-01)